Holen Sie sich die Stockscreener-App
0.332
37.53%
0.0906
Vorhandelsmarkt:
.33
-0.002
-0.60%
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
MTNB|Matinas BioPharma Holdings Inc|Price:0.335|Chg%:+0.093 - TradingKey
Matinas BioPharma Holdings Inc - TradingKey
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket - Benzinga
Matinas BioPharma Holdings Inc (MTNB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Institutional Confidence - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
Matinas Biopharma Holdings, Inc. Revenue Breakdown – AMEX:MTNB - TradingView
Trending Stocks Today | Matinas BioPharma Surges 44.65% Post-Market - Moomoo
Matinas BioPharma Ends At-The-Market Sales Agreement - TipRanks
Matinas BiopharmaBtig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026SEC Filing - TradingView
Matinas BioPharma $50 Million ATM Program With BTIG Terminated With No Penalties - TradingView
Matinas BioPharma Holdings Inc (MTNB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate M - Hydrogen Central
[425] Matinas BioPharma Holdings, Inc. Business Combination Communication - Stock Titan
Matinas BioPharma Holdings Inc (NYSE: MTNB) Share Price, MTNB Stock News, MTNB Share Price & Updates - Kalkine
Matinas BioPharma (NYSE: MTNB) to combine with GH Power in new Ontario holdco - Stock Titan
GH Power Goes Public via Matinas BioPharma Merger - Fuel Cells Works
GH Power To Go Public Through Business Combination With Matinas BioPharma - Pulse 2.0
Nasdaq Surges Over 100 Points; Bank of America Earnings Top Views - Sahm
Hezbay builds 9.54% position in Matinas BioPharma (MTNB) - Stock Titan
Matinas BioPharma forms business tie-up with GH Power to create clean energy and green hydrogen company - ROI-NJ
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
United StatesLowenstein Represents Matinas BioPharma In Strategic Business Combination With GH Power And Divestiture Of Matinas BioPharma Nanotechnologies, Inc. - Mondaq
GH Power to go public via merger with Matinas BioPharma By Investing.com - Investing.com Nigeria
GH Power to go public via Matinas BioPharma merger - scanx.trade
GH Power to go public via merger with Matinas BioPharma - Investing.com
GH Power, the Pioneering Clean Energy and Critical Materials Company, to Go Public through Business Combination with Matinas BioPharma - Yahoo Finance
Matinas BioPharma to Merge with GH Power, Selling LNC Platform to Azurity in Major Clean Energy & Pharma Deal - Minichart
Matinas BioPharma to Merge with GH Power International - TipRanks
Matinas BioPharma (MTNB) Engages in Strategic Business Combinati - GuruFocus
Matinas BioPharma (NYSE: MTNB) plans GH Power merger and $21.5M Azurity sale - Stock Titan
Matinas BioPharma (NYSE: MTNB) plans GH Power merger and $21.5M Azurity asset sale - Stock Titan
Press Release: Matinas BioPharma Announces Strategic Business Combination With GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Produ - Moomoo
Biotech Matinas pivots into green hydrogen as GH Power goes public in NYSE deal - Stock Titan
Matinas BioPharma Company Profile & Introduction - Moomoo
MSN Money - MSN
12 Health Care Stocks Moving In Wednesday's Pre-Market SessionCan Fite Biopharma (AMEX:CANF), Atlantic - Benzinga
Matinas Biopharma Shares Edge Higher, Approaching Key Resistance LevelIV Expansion Alert - DonanımHaber
Price to earnings forward of Matinas Biopharma Holdings, Inc. – AMEX:MTNB - TradingView
Price to earnings forward of Matinas BioPharma Holdings, Inc. – GETTEX:6LJ0 - TradingView
Price to book forward of Matinas Biopharma Holdings, Inc. – AMEX:MTNB - TradingView
Price to sales forward of Matinas BioPharma Holdings, Inc. – GETTEX:6LJ0 - TradingView
Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – GETTEX:6LJ0 - TradingView
Enterprise value to EBIT forward of Matinas BioPharma Holdings, Inc. – GETTEX:6LJ0 - TradingView
Matinas BioPharma receives NYSE delisting plan extension - Investing.com UK
Matinas BioPharma receives NYSE delisting plan extension By Investing.com - Investing.com Nigeria
Matinas BioPharma Receives NYSE American Non-Compliance Notice, Granted Plan Period to Regain Listing Standards - Minichart
Matinas BioPharma (MTNB) Faces NYSE Equity Compliance Challenge - GuruFocus
Matinas BioPharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Matinas BioPharma (NYSE: MTNB) put on NYSE American equity compliance plan to avoid delisting - Stock Titan
Matinas BioPharma's High-Stakes Gamble to Keep its NYSE Listing Alive - BriefGlance
Matinas BioPharma Holdings, Inc. Actuals & Estimates (GETTEX:6LJ0) - TradingView
Matinas BioPharma Holdings, Inc. Actuals & Estimates (AMEX:MTNB) - TradingView
Matinas BioPharma Holdings Inc (MTNB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Matinas Biopharma (MTNB) Rises 2.75% as Stock Tests Key ResistanceHigh Volume Stocks - DonanımHaber
Matinas Biopharma (MTNB) updates selling holders for 16,894,212-share resale registration - Stock Titan
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):